UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Fragmin® 2500 IE/ml Injektionsvätska, lösning
- Invented name part: Fragmin®
- Strength part: 2500 IE/ml
- Pharmaceutical dose form part: injektionsvätska, lösning
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Solution for injection
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 10754
Region: Kingdom of Sweden
Marketing authorisation holder: Pfizer AB
Identifier:
Status: Valid (1988-03-18)
Package 1 of 1
PCID:
Description: Injektionsflaska, 10 x 4 ml
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 10 Vial (Glass)
Containing: 10 Vial
Manufactured Item
Dose form: Solution for injection
Unit of presentation: Vial
Ingredient
Role: Active
Substance: dalteparin sodium
Concentration strength: quantity sufficient / 1 unit(s)
Reference strength: dalteparin 2500 international unit(s) / 1 millilitre(s)
Administrable Product (1 of 1)
Dose form: Solution for injection
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: dalteparin sodium
Concentration strength: quantity sufficient / 1 unit(s)
Reference strength: dalteparin 2500 international unit(s) / 1 millilitre(s)